← All Investors
ARBUTUS BIOPHARMA CORP
ABUS
Holders
4
Combined Value
$6M
Combined Shares
1,468,826
Current Price
$4.43
52W High
$5.10
vs 52W High
−13.1%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Ken Griffin - Citadel Advisors | $3M | 0.00% | ~$4.36 | +1.6% | Bought Q1 2026 | Q1 2026 |
| Israel Englander - Millennium Management | $2M | 0.00% | ~$4.50 | −1.6% | Bought Q1 2026 | Q1 2026 |
| Cliff Asness - AQR Capital | $107K | 0.00% | ~$3.99 | +11.0% | Bought Q1 2026 | Q1 2026 |
| Joel Greenblatt - Gotham Asset Management | $77K | 0.00% | ~$4.50 | −1.6% | Bought Q1 2026 | Q1 2026 |
Recent Activity
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 4 | 1,468,826 | +784.2% | $6M | $4.50 |
| Q4 2025 | 2 | 166,126 | −79.8% | $799K | $4.81 |
| Q3 2025 | 3 | 820,664 | +7.3% | $3M | $4.54 |
| Q2 2025 | 3 | 764,957 | +25.1% | $2M | $3.09 |
| Q1 2025 | 3 | 611,304 | −18.7% | $2M | $3.49 |
| Q4 2024 | 3 | 751,811 | −23.5% | $2M | $3.27 |
| Q3 2024 | 3 | 982,422 | +141.1% | $3M | $3.85 |
| Q2 2024 | 2 | 407,444 | — | $1M | $3.09 |